Order Article Reprints

Takahashi N, Nakashima R, Nasu A, Hayashi M, Fujikawa H, Kawakami T, Eto Y, Kishimoto T, Fukuyama A, Ogasawara C, et al. T₃ Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model. Antioxidants. 2024; 13(1):30. https://doi.org/10.3390/antiox13010030

Takahashi, Noriki, Ryunosuke Nakashima, Aoi Nasu, Megumi Hayashi, Haruka Fujikawa, Taisei Kawakami, Yuka Eto, Tomoki Kishimoto, Ayami Fukuyama, Choyo Ogasawara, and et al. 2024. "T₃ Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model" Antioxidants 13, no. 1: 30. https://doi.org/10.3390/antiox13010030

Takahashi, N., Nakashima, R., Nasu, A., Hayashi, M., Fujikawa, H., Kawakami, T., Eto, Y., Kishimoto, T., Fukuyama, A., Ogasawara, C., Kawano, K., Fujiwara, Y., Suico, M. A., Kai, H., & Shuto, T. (2024). T₃ Intratracheal Therapy Alleviates Pulmonary Pathology in an Elastase-Induced Emphysema-Dominant COPD Mouse Model. Antioxidants, 13(1), 30. https://doi.org/10.3390/antiox13010030